Allergen Capture by DCs during epicutaneous immunotherapy is Enhanced by Modulating the Dose and the Surface Area of the Patch

Rationale Epicutaneous immunotherapy for the treatment of food allergy is effective and safe in animal models and in humans, as recently shown in a Phase II trial demonstrating the crucial role of the dose.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of allergy and clinical immunology 2017-02, Vol.139 (2), p.AB257-AB257
Hauptverfasser: Wavrin, Sophie, Mondoulet, Lucie, Dioszeghy, Vincent, PhD, Puteaux, Emilie, Ligouis, Melanie, Dhelft, Véronique, Plaquet, Camille, Dupont, Christophe M., MD, PhD, Benhamou, Pierre-Henri, Sampson, Hugh A., MD, FAAAAI
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page AB257
container_issue 2
container_start_page AB257
container_title Journal of allergy and clinical immunology
container_volume 139
creator Wavrin, Sophie
Mondoulet, Lucie
Dioszeghy, Vincent, PhD
Puteaux, Emilie
Ligouis, Melanie
Dhelft, Véronique
Plaquet, Camille
Dupont, Christophe M., MD, PhD
Benhamou, Pierre-Henri
Sampson, Hugh A., MD, FAAAAI
description Rationale Epicutaneous immunotherapy for the treatment of food allergy is effective and safe in animal models and in humans, as recently shown in a Phase II trial demonstrating the crucial role of the dose.
doi_str_mv 10.1016/j.jaci.2016.12.827
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1867942265</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0091674916323454</els_id><sourcerecordid>4313580231</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2727-47c3feca51674bd501c2c35446e25092ba94a185dc418e5fcfc0ea8218ae60653</originalsourceid><addsrcrecordid>eNp9kV2L1DAUhosoOK7-Aa8CXrcmadIPEGGYXd2FFYXV63Dm9HQntZPUpBHmxt9uOyMIXniVnPA-yclzsuy14IXgono7FAOgLeSyL4QsGlk_yTaCt3VeNVI_zTactyKvatU-z17EOPClLpt2k_3ajiOFR3JsB9OcArH9iV3vIutSsO6R0WQxzeDIp8js8Zicnw8UYDoxG9mNO4BD6lbok-_SCPMKLQl27SMxcN25eEihByS2DQTM9-ezLzDj4WX2rIcx0qs_61X27cPN191tfv_5491ue5-jrGWdqxrLnhC0WL6w7zQXKLHUSlUkNW_lHloFotEdKtGQ7rFHTtBI0QBVvNLlVfbmcu8U_I9EcTaDT8EtTxrRVHWrpDyn5CWFwccYqDdTsEcIJyO4WT2bwayezerZCGkWzwv07gLR0v9PS8FEtLRasYFwNp23_8ff_4PjaJ1FGL_TieLfNk2UhpuHdZDrHEVVylJpVf4GBJ2bhg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1867942265</pqid></control><display><type>article</type><title>Allergen Capture by DCs during epicutaneous immunotherapy is Enhanced by Modulating the Dose and the Surface Area of the Patch</title><source>Elsevier ScienceDirect Journals</source><source>EZB Electronic Journals Library</source><creator>Wavrin, Sophie ; Mondoulet, Lucie ; Dioszeghy, Vincent, PhD ; Puteaux, Emilie ; Ligouis, Melanie ; Dhelft, Véronique ; Plaquet, Camille ; Dupont, Christophe M., MD, PhD ; Benhamou, Pierre-Henri ; Sampson, Hugh A., MD, FAAAAI</creator><creatorcontrib>Wavrin, Sophie ; Mondoulet, Lucie ; Dioszeghy, Vincent, PhD ; Puteaux, Emilie ; Ligouis, Melanie ; Dhelft, Véronique ; Plaquet, Camille ; Dupont, Christophe M., MD, PhD ; Benhamou, Pierre-Henri ; Sampson, Hugh A., MD, FAAAAI</creatorcontrib><description>Rationale Epicutaneous immunotherapy for the treatment of food allergy is effective and safe in animal models and in humans, as recently shown in a Phase II trial demonstrating the crucial role of the dose.</description><identifier>ISSN: 0091-6749</identifier><identifier>EISSN: 1097-6825</identifier><identifier>DOI: 10.1016/j.jaci.2016.12.827</identifier><language>eng</language><publisher>St. Louis: Elsevier Inc</publisher><subject>Allergies ; Allergy and Immunology ; Immunotherapy ; Rodents</subject><ispartof>Journal of allergy and clinical immunology, 2017-02, Vol.139 (2), p.AB257-AB257</ispartof><rights>2016</rights><rights>Copyright Elsevier Limited Feb 01, 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2727-47c3feca51674bd501c2c35446e25092ba94a185dc418e5fcfc0ea8218ae60653</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0091674916323454$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids></links><search><creatorcontrib>Wavrin, Sophie</creatorcontrib><creatorcontrib>Mondoulet, Lucie</creatorcontrib><creatorcontrib>Dioszeghy, Vincent, PhD</creatorcontrib><creatorcontrib>Puteaux, Emilie</creatorcontrib><creatorcontrib>Ligouis, Melanie</creatorcontrib><creatorcontrib>Dhelft, Véronique</creatorcontrib><creatorcontrib>Plaquet, Camille</creatorcontrib><creatorcontrib>Dupont, Christophe M., MD, PhD</creatorcontrib><creatorcontrib>Benhamou, Pierre-Henri</creatorcontrib><creatorcontrib>Sampson, Hugh A., MD, FAAAAI</creatorcontrib><title>Allergen Capture by DCs during epicutaneous immunotherapy is Enhanced by Modulating the Dose and the Surface Area of the Patch</title><title>Journal of allergy and clinical immunology</title><description>Rationale Epicutaneous immunotherapy for the treatment of food allergy is effective and safe in animal models and in humans, as recently shown in a Phase II trial demonstrating the crucial role of the dose.</description><subject>Allergies</subject><subject>Allergy and Immunology</subject><subject>Immunotherapy</subject><subject>Rodents</subject><issn>0091-6749</issn><issn>1097-6825</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp9kV2L1DAUhosoOK7-Aa8CXrcmadIPEGGYXd2FFYXV63Dm9HQntZPUpBHmxt9uOyMIXniVnPA-yclzsuy14IXgono7FAOgLeSyL4QsGlk_yTaCt3VeNVI_zTactyKvatU-z17EOPClLpt2k_3ajiOFR3JsB9OcArH9iV3vIutSsO6R0WQxzeDIp8js8Zicnw8UYDoxG9mNO4BD6lbok-_SCPMKLQl27SMxcN25eEihByS2DQTM9-ezLzDj4WX2rIcx0qs_61X27cPN191tfv_5491ue5-jrGWdqxrLnhC0WL6w7zQXKLHUSlUkNW_lHloFotEdKtGQ7rFHTtBI0QBVvNLlVfbmcu8U_I9EcTaDT8EtTxrRVHWrpDyn5CWFwccYqDdTsEcIJyO4WT2bwayezerZCGkWzwv07gLR0v9PS8FEtLRasYFwNp23_8ff_4PjaJ1FGL_TieLfNk2UhpuHdZDrHEVVylJpVf4GBJ2bhg</recordid><startdate>20170201</startdate><enddate>20170201</enddate><creator>Wavrin, Sophie</creator><creator>Mondoulet, Lucie</creator><creator>Dioszeghy, Vincent, PhD</creator><creator>Puteaux, Emilie</creator><creator>Ligouis, Melanie</creator><creator>Dhelft, Véronique</creator><creator>Plaquet, Camille</creator><creator>Dupont, Christophe M., MD, PhD</creator><creator>Benhamou, Pierre-Henri</creator><creator>Sampson, Hugh A., MD, FAAAAI</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7SS</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>20170201</creationdate><title>Allergen Capture by DCs during epicutaneous immunotherapy is Enhanced by Modulating the Dose and the Surface Area of the Patch</title><author>Wavrin, Sophie ; Mondoulet, Lucie ; Dioszeghy, Vincent, PhD ; Puteaux, Emilie ; Ligouis, Melanie ; Dhelft, Véronique ; Plaquet, Camille ; Dupont, Christophe M., MD, PhD ; Benhamou, Pierre-Henri ; Sampson, Hugh A., MD, FAAAAI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2727-47c3feca51674bd501c2c35446e25092ba94a185dc418e5fcfc0ea8218ae60653</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Allergies</topic><topic>Allergy and Immunology</topic><topic>Immunotherapy</topic><topic>Rodents</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wavrin, Sophie</creatorcontrib><creatorcontrib>Mondoulet, Lucie</creatorcontrib><creatorcontrib>Dioszeghy, Vincent, PhD</creatorcontrib><creatorcontrib>Puteaux, Emilie</creatorcontrib><creatorcontrib>Ligouis, Melanie</creatorcontrib><creatorcontrib>Dhelft, Véronique</creatorcontrib><creatorcontrib>Plaquet, Camille</creatorcontrib><creatorcontrib>Dupont, Christophe M., MD, PhD</creatorcontrib><creatorcontrib>Benhamou, Pierre-Henri</creatorcontrib><creatorcontrib>Sampson, Hugh A., MD, FAAAAI</creatorcontrib><collection>CrossRef</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><jtitle>Journal of allergy and clinical immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wavrin, Sophie</au><au>Mondoulet, Lucie</au><au>Dioszeghy, Vincent, PhD</au><au>Puteaux, Emilie</au><au>Ligouis, Melanie</au><au>Dhelft, Véronique</au><au>Plaquet, Camille</au><au>Dupont, Christophe M., MD, PhD</au><au>Benhamou, Pierre-Henri</au><au>Sampson, Hugh A., MD, FAAAAI</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Allergen Capture by DCs during epicutaneous immunotherapy is Enhanced by Modulating the Dose and the Surface Area of the Patch</atitle><jtitle>Journal of allergy and clinical immunology</jtitle><date>2017-02-01</date><risdate>2017</risdate><volume>139</volume><issue>2</issue><spage>AB257</spage><epage>AB257</epage><pages>AB257-AB257</pages><issn>0091-6749</issn><eissn>1097-6825</eissn><abstract>Rationale Epicutaneous immunotherapy for the treatment of food allergy is effective and safe in animal models and in humans, as recently shown in a Phase II trial demonstrating the crucial role of the dose.</abstract><cop>St. Louis</cop><pub>Elsevier Inc</pub><doi>10.1016/j.jaci.2016.12.827</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0091-6749
ispartof Journal of allergy and clinical immunology, 2017-02, Vol.139 (2), p.AB257-AB257
issn 0091-6749
1097-6825
language eng
recordid cdi_proquest_journals_1867942265
source Elsevier ScienceDirect Journals; EZB Electronic Journals Library
subjects Allergies
Allergy and Immunology
Immunotherapy
Rodents
title Allergen Capture by DCs during epicutaneous immunotherapy is Enhanced by Modulating the Dose and the Surface Area of the Patch
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T14%3A51%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Allergen%20Capture%20by%20DCs%20during%20epicutaneous%20immunotherapy%20is%20Enhanced%20by%20Modulating%20the%20Dose%20and%20the%20Surface%20Area%20of%20the%20Patch&rft.jtitle=Journal%20of%20allergy%20and%20clinical%20immunology&rft.au=Wavrin,%20Sophie&rft.date=2017-02-01&rft.volume=139&rft.issue=2&rft.spage=AB257&rft.epage=AB257&rft.pages=AB257-AB257&rft.issn=0091-6749&rft.eissn=1097-6825&rft_id=info:doi/10.1016/j.jaci.2016.12.827&rft_dat=%3Cproquest_cross%3E4313580231%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1867942265&rft_id=info:pmid/&rft_els_id=S0091674916323454&rfr_iscdi=true